Related Experiment Video
Updated: Jun 3, 2026
04:36
An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
Diabetic retinopathy: current developments in pathogenesis and management
1Retina and Vitreous Unit, Department of Ophthalmology, University College Hospital, P M B 5116, Ibadan, Nigeria. t_oluleye@yahoo.co.uk
African Journal of Medicine and Medical Sciences
|March 22, 2011
Summary
Diabetic retinopathy is a growing cause of vision loss in developing nations. This review highlights key developments in its understanding and management, including new treatments and screening importance.
Area of Science:
- Ophthalmology
- Endocrinology
- Medical Science
Background:
- Diabetic retinopathy is a significant cause of visual impairment, particularly in developing countries.
- Changing lifestyles contribute to the increasing prevalence of diabetes and its ocular complications.
Purpose of the Study:
- To review recent advancements in the pathogenesis of diabetic retinopathy.
- To highlight the role of Protein Kinase C and Vascular Endothelial Growth Factor in disease development.
- To discuss atypical presentations, pharmacological treatments, and screening strategies for diabetic retinopathy.
Main Methods:
- Literature review of recent developments in diabetic retinopathy research.
- Emphasis on molecular mechanisms and clinical management strategies.
Main Results:
- Protein Kinase C and Vascular Endothelial Growth Factor are key players in diabetic retinopathy pathogenesis.
- Atypical presentations require careful consideration in diagnosis.
- Pharmacological agents and regular screening are crucial for effective management.
Conclusions:
- Awareness of recent developments in diabetic retinopathy is essential for healthcare professionals in Nigeria.
- Early detection and appropriate management can mitigate visual impairment caused by diabetic retinopathy.
Related Concept Videos
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...